T1	Participants 82 130	chronic stage II and stage III decubitus ulcers.
T2	Participants 288 336	stage II and stage III chronic decubitus ulcers.
T3	Participants 345 394	Seventy-four ulcers were treated in four centers.
T4	Participants 395 523	Forty-three patients were selected for the experimental group, and 31 control subjects used the sham instrument (placebo group).
